학술논문

Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study.
Document Type
Article
Source
Journal of Crohn's & Colitis; Sep2022, Vol. 16 Issue 9, p1436-1446, 11p
Subject
Language
ISSN
18739946